US Patent Issued to Takeda Pharmaceutical on Dec. 9 for "Cleaved high molecule weight kininogen (HMWK) antibodies and methods of using" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,493,047, issued on Dec. 9, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Cleaved high molecule weight kininogen (HMWK) antibodies and methods of using" was invented by Daniel J. Sexton (Melrose, Mass.), Ryan Faucette (Melrose, Mass.) and Janja Cosic (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides immunoassay methods of detecting a cleaved high molecular weight kininogen (HMWK) with high sensitivity and specificity and isolated antibodies that specifically bind cleaved HMWK."

The patent was filed on Jan. 5, 2021, under Application No. 17/141,690.

*For further information, including image...